3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Conditions
Neoplasms
9
Leukemia, Myeloid, Acute
7
Leukemia
5
Carcinoma
3
Myelodysplastic Syndromes
2
Hematologic Diseases
2
Small Cell Lung Carcinoma
1
Sarcoma, Myeloid
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Carcinoma, Small Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Acute Disease
1
Interventions
Cytarabine
3
Mitoxantrone
2
vosaroxin
1
devimistat
1
Stem Cell Transplantation
1
Sorafenib
1
Leyk
1
Hematopoietic Stem Cell Transplantation
1
Etoposide
1
Daunorubicin
1
Bortezomib
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma, Myeloid
×
vosaroxin
×
Clear all
NCT02658487
2025-04-15
VITAL
Vanderbilt-Ingram Cancer Center
Phase 2
Completed
42 enrolled
12 charts